Skip to main content
Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
111.90
-4.23 (-3.64%)
Nov 4, 2024, 4:00 PM EST - Market closed

Cardinal Health Revenue by Segment
Period Ending Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Pharmaceutical Revenue
210.79B 204.88B 201.03B 195.19B 190.01B 183.65B 177.80B 171.50B
Pharmaceutical Revenue Growth
10.93% 11.56% 13.07% 13.81% 14.82% 14.42% 14.97% 13.95%
Medical Revenue
13.91B 14.56B 15.13B 15.00B 15.01B 15.03B 15.23B 15.52B
Medical Revenue Growth
-7.35% -3.14% -0.66% -3.35% -5.50% -8.16% -8.56% -8.08%

Profit by Segment
Period Ending Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Pharmaceutical
2.09B 2.11B 2.13B 2.08B 2.00B 1.95B 1.83B 1.80B
Pharmaceutical Growth
4.40% 8.38% 16.15% 15.60% 12.94% 16.04% 7.76% 6.34%
Medical
209.00M 244.00M 244.00M 190.00M 111.00M 13.00M 52.00M 85.00M
Medical Growth
88.29% 1,776.92% 369.23% 123.53% -48.61% -92.31% -81.69% -81.91%

Profit Margin by Segment
Period Ending Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Medical Profit Margin
1.51% 0.64% 1.81% 1.89% 2.18% 0.54% 0.45% -0.21%
Pharmaceutical Profit Margin
0.87% 1.15% 0.97% 0.99% 1.01% 1.28% 0.97% 0.94%

Operating Expense Breakdown
Period Ending Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Distribution, Selling, General, and Administrative
5.04B 5.03B 4.93B 4.83B 4.83B 4.72B 4.68B 4.64B
Distribution, Selling, General, and Administrative Growth
4.24% 6.50% 5.26% 4.18% 6.08% 4.22% 3.68% 2.88%
Amortization and Other Acquisition-Related Costs
284.00M 276.00M 270.00M 278.00M 285.00M 303.00M 308.00M 316.00M
Amortization and Other Acquisition-Related Costs Growth
-0.35% -8.91% -12.34% -12.03% -12.04% -11.66% -17.87% -23.30%
Restructuring and Employee Severance
175.00M 139.00M 102.00M 91.00M 95.00M 107.00M 122.00M 112.00M
Restructuring and Employee Severance Growth
84.21% 29.91% -16.39% -18.75% -5.94% 20.22% 48.78% 17.89%
Litigation Charges, Net
79.00M -17.00M -174.00M -370.00M -302.00M -260.00M -123.00M 118.00M
Litigation Charges, Net Growth
- - - - - - - 8.26%
Impairments and (Gain)/Loss on Disposal of Assets, Net
630.00M 989.00M 925.00M 1.63B 1.25B 1.17B 1.62B 2.21B
Impairments and (Gain)/Loss on Disposal of Assets, Net Growth
-49.60% -15.40% -42.90% -25.90% -39.02% -33.77% 18.86% 3,142.65%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.